Europe — EMA
Octreoscan (Indium In-111 Pentetreotide)
Indium In-111 pentapeptide, the active ingredient in Octreoscan, is a radiopharmaceutical presented as a solution for intravenous use.
Request sourcing
What is Indium In-111 Pentetreotide?
Indium In-111 pentapeptide, the active ingredient in Octreoscan, is a radiopharmaceutical presented as a solution for intravenous use. It binds to somatostatin receptors and is used in diagnostic imaging to locate neuroendocrine tumors and assess disease spread in adult patients. GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.
GNH USA supplies Octreoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.
What is Indium In-111 Pentetreotide used for?
Octreoscan is employed in nuclear medicine to image somatostatin receptor‑positive lesions, particularly within the neuroendocrine tumor spectrum. - Gastroenteropancreatic neuroendocrine tumors: helps obtain precise localisation of primary tumours and metastases. - Bronchial carcinoid tumors: aids in detect ing lesions for staging and treatment planning. - Small cell lung cancer (SCLC): facilitates tumor localisation for therapy selection and response assessment in adult patients over 18 years of age by S PECT imaging with In‑11
What are the side effects of Indium In-111 Pentetreotide?
This … … ...
What precautions apply to Indium In-111 Pentetreotide?
...
What does Indium In-111 Pentetreotide interact with?
...
